These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 4611183)

  • 1. Drug effectiveness on experimental optokinetic and vestibular motion sickness.
    Brandt T; Dichgans J; Wagner W
    Aerosp Med; 1974 Nov; 45(11):1291-7. PubMed ID: 4611183
    [No Abstract]   [Full Text] [Related]  

  • 2. A reduction of vestibulo-visual integration during transdermally administered scopolamine and dimenhydrinate. A presentation of gain control theory in motion sickness.
    Pyykkö I; Schalén L; Jäntti V; Magnusson M
    Acta Otolaryngol Suppl; 1984; 406():167-73. PubMed ID: 6332454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motion sickness is linked to nystagmus-related trigeminal brain stem input: a new hypothesis.
    Gupta VK
    Med Hypotheses; 2005; 64(6):1177-81. PubMed ID: 15823712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central aspects of drugs for motion sickness and vertigo.
    McCabe BF
    Adv Otorhinolaryngol; 1973; 20():458-69. PubMed ID: 4575761
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural elements in the concept of motion sickness.
    Graybiel A
    Aerosp Med; 1969 Apr; 40(4):351-67. PubMed ID: 5305044
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of experimental motion sickness on postrotatory nystagmus and the illusion of counterrotation].
    Aĭzikov GS; Kliushnikova ON
    Kosm Biol Aviakosm Med; 1985; 19(2):89-91. PubMed ID: 3990240
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of scopolamine and cyclizine on visual-vestibular interaction in humans.
    Gowans J; Matheson A; Darlington CL; Smith PF
    J Vestib Res; 2000; 10(2):87-92. PubMed ID: 10939683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the effectiveness of vestibular, optokinetic and optovestibular stimulation in the experimental model of motion sickness].
    Matsner EI; Kuz'min MP; Zakharova LN
    Vestn Otorinolaringol; 1986; (1):10-7. PubMed ID: 3485322
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli.
    Collins WE; Schroeder DJ; Elam GW
    Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectivity of antimotion sickness drugs during artificial gravity simulations.
    Green JA
    Aerosp Med; 1973 Nov; 44(11):1255-60. PubMed ID: 4586812
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of vestibular training on motion sickness, nystagmus, and subjective vertical.
    Clément G; Deguine O; Bourg M; Pavy-LeTraon A
    J Vestib Res; 2007; 17(5-6):227-37. PubMed ID: 18626134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermally administered scopolamine vs. dimenhydrinate. II. Effect on different types of nystagmus.
    Pyykkö I; Schalén L; Matsuoka I
    Acta Otolaryngol; 1985; 99(5-6):597-604. PubMed ID: 4024910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of vestibular nystagmus and "vertigo" by means of visual stimulation.
    Collins WE
    Trans Am Acad Ophthalmol Otolaryngol; 1968; 72(6):962-79. PubMed ID: 5303736
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of diphenhydramine and dimenhydrinate on vestibular neuronal activity of cat: a search for the locus of their antimotion sickness action.
    Jaju BP; Wang SC
    J Pharmacol Exp Ther; 1971 Mar; 176(3):718-24. PubMed ID: 4329456
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental study of some features of the etiology and pathogenesis of motion sickness.
    Solodovnik FA
    Biol Bull Acad Sci USSR; 1978; 5(2):204-11. PubMed ID: 311224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coriolis acceleration. Vestibulo-vegetative stimulations with regard to the motion sickness of astronauts. Experimental researches].
    Arslan M; Martini A; Razzolini R
    Minerva Med; 1976 Jul; 67(36):2347-9. PubMed ID: 1084969
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of anti-seasick properties of pyrroxan and dimenhydrinate under conditions of maximal and submaximal statokinetic load in humans].
    Shabanov PD; Anokhin AG
    Eksp Klin Farmakol; 2005; 68(3):50-5. PubMed ID: 16047682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness.
    Muth ER; Jokerst M; Stern RM; Koch KL
    Aviat Space Environ Med; 1995 Nov; 66(11):1041-5. PubMed ID: 8588792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motion sickness induced by optokinetic drums.
    Bos JE; Bles W
    Aviat Space Environ Med; 2004 Feb; 75(2):172-4. PubMed ID: 14960055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.